Evidence map›Paper›PMID 32947029›Full record

ArticlePhotodiagnosis and photodynamic therapy2020

Improved antimicrobial properties of methylene blue attached to silver nanoparticles.

Ermek Belekov, Khomidkhodza Kholikov, Lauren Cooper, Simran Banga, Ali O Er

Open access · greenAbstract read
In one paragraph

Article in Photodiagnosis and photodynamic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ermek BelekovWestern Kentucky University, Department of Physics and Astronomy, Bowling Green, KY, 42101, United States.
Khomidkhodza KholikovWestern Kentucky University, Department of Physics and Astronomy, Bowling Green, KY, 42101, United States.
Lauren CooperWestern Kentucky University, Department of Physics and Astronomy, Bowling Green, KY, 42101, United States.
Simran BangaWestern Kentucky University, Department of Biology, Bowling Green, KY, 42101, United States.
Ali O ErWestern Kentucky University, Department of Physics and Astronomy, Bowling Green, KY, 42101, United States. Electronic address: ali.er@wku.edu.
Western Kentucky University · US

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
NIGMS NIH HHS P20 GM103436
6 · The paper itself

Abstract

Photosensitizing agents are the cornerstone of Photodynamic Therapy (PDT). They play an essential role in deactivation process of multidrug resistant pathogens and tumor treatments. In this work, we studied a photosensitizing agent made from mixture of Silver Nanoparticles (Ag NPs) and Methylene Blue (MB) which possess improved important characteristics like high photostability and high singlet oxygen yield. Ag NPs were synthesized by pulsed laser ablation technique in different aqueous solutions like polyvinylpyrrolidone (PVP), citrate and Deionized (DI) water. The synthesized AgNPs were characterized in depth using with transmission electron microscopy (TEM), UV-vis (UV-vis), and photoluminescence (PL) spectra. These Ag NPs were combined with MB and used to eradicate the Gram-negative bacteria, Escherichia coli (E. coli), and Gram-positive bacteria, Staphylococcus aureus (S. aureus). MB and Ag NPs mixture was found to possess higher antimicrobial activity and thus were more effective in killing both Gram -positive and Gram-negative bacteria in comparison to individual exposure of MB and Ag NPs. Additionally, the antimicrobial effects varied with respect to the size of nanoparticles as well as the medium used for their synthesis. The data from this study supports the potential use of the proposed method in PDT where standard photosensitizers have limitations.

Indexed as

Anti-Infective AgentsMetal NanoparticlesPhotochemotherapyAnti-Bacterial AgentsEscherichia coliMethylene BluePhotosensitizing AgentsSilverStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsMethylene BluePhotosensitizing AgentsSilverBacteria deactivationMethylene bluePhotodynamic therapySilver nanoparticles

Identifiers

PMID32947029
PMCPMC8579323
OpenAlexW3087536746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.